Skip to content
10-Q

Quarterly Report

American Oncology Network, Inc.

0001839998-23-000007

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Long Term Debt Q3 2023 · Sep 30, 2023 $80.43M
Long Term Debt Q3 2023 · Dec 31, 2022 $80.3M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $51.65M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $26.93M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$341.33M
Current Liabilities Q3 2023 · Sep 30, 2023 $167.9M
Current Liabilities Q3 2023 · Dec 31, 2022 $140.94M
Total Liabilities Q3 2023 · Sep 30, 2023 $300.92M
Total Liabilities Q3 2023 · Dec 31, 2022 $264.21M
Current Assets Q3 2023 · Sep 30, 2023 $298.39M
Current Assets Q3 2023 · Dec 31, 2022 $242.02M
Total Assets Q3 2023 · Sep 30, 2023 $394.01M
Total Assets Q3 2023 · Dec 31, 2022 $326.23M
Net Income Q3 2023 · Sep 30, 2023 −$1.79M
Shares Diluted Q3 2023 · Sep 30, 2022 0 sh
Shares Diluted Q3 2023 · Sep 30, 2022 0 sh
Capex Q3 2023 · Sep 30, 2022 $5.05M
Operating Cash Flow restated Q3 2023 · Sep 30, 2022 $1.63M
Eps Diluted Q3 2023 · Sep 30, 2022 $0.00
Eps Diluted Q3 2023 · Sep 30, 2022 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 $0.00
Sga Expense Q3 2023 · Sep 30, 2022 $23.43M
Sga Expense Q3 2023 · Sep 30, 2022 $66.16M
Operating Income restated Q3 2023 · Sep 30, 2022 $6.09M
Operating Income restated Q3 2023 · Sep 30, 2022 $2.31M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $267.65M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $780.66M
Revenue Q3 2023 · Sep 30, 2022 $297.32M
Revenue Q3 2023 · Sep 30, 2022 $849.27M